Neuroscientist. 2005 Oct;11(5):452-70.

Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.

Source

Neuroscience Discovery, Eli Lilly & Co., Indianapolis, Indiana 46285-0510, USA. cyang@lilly.com

Abstract

The prefrontal cortex plays a principal role in higher cognition and particularly in the fast online manipulation of appropriate information to guide forthcoming behavior. Dysfunction of this process represents a main feature in the pathophysiology of schizophrenia. Both dopamine D1 and N-methyl-D-aspartate (NMDA) receptors in the prefrontal cortex play a critical role in synaptic plasticity, memory mechanisms, and cognition. Recent data have shown that D1 and NMDA receptors interact bidirectionally and may greatly influence the output of the prefrontal cortex. Hypofunction of these receptor systems in the prefrontal cortex is found in schizophrenia. This review attempts to summarize some of the latest findings on the cellular mechanisms that underlie D1-NMDA receptor interactions. These findings have provided potential therapeutic strategies that aim to functionally up-regulate D1 and/or NMDA receptor safely via selective activation of D1 receptors or coagonist activation of NMDA receptors through blockade of the glycine transporter-1.

PMID:: 16151046; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Schizophrenia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. [Mol Pharmacol. 2007]
Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A, Noda Y, Noda A, Nakamura T, Tokura T, Yura Y, Nitta A, Furukawa H, Nabeshima T. Mol Pharmacol. 2007 Jun; 71(6):1598-609. Epub 2007 Mar 7.
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. [Eur Neuropsychopharmacol. 2009]
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex.
Kruse MS, Prémont J, Krebs MO, Jay TM. Eur Neuropsychopharmacol. 2009 Apr; 19(4):296-304. Epub 2009 Jan 31.
Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex. [Naunyn Schmiedebergs Arch Phar...]
Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
Abekawa T, Ito K, Koyama T. Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec; 374(3):177-93. Epub 2006 Nov 14.
Review Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. [Brain Cogn. 2007]
Review Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex.
Castner SA, Williams GV. Brain Cogn. 2007 Mar; 63(2):94-122. Epub 2007 Jan 3.
Review The NMDA/D1 receptor complex as a new target in drug development. [Curr Top Med Chem. 2006]
Review The NMDA/D1 receptor complex as a new target in drug development.
Missale C, Fiorentini C, Busi C, Collo G, Spano PF. Curr Top Med Chem. 2006; 6(8):801-8.

See reviews... See all...

Cited by 9 PubMed Central articles

Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses. [PLoS One. 2011]
Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.
Yan J, Xu Y, Zhu C, Zhang L, Wu A, Yang Y, Xiong Z, Deng C, Huang XF, Yenari MA, et al. PLoS One. 2011; 6(6):e20945. Epub 2011 Jun 22.
Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia. [J Am Acad Child Adolesc Psychi...]
Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia.
Mattai AA, Weisinger B, Greenstein D, Stidd R, Clasen L, Miller R, Tossell JW, Rapoport JL, Gogtay N. J Am Acad Child Adolesc Psychiatry. 2011 Jul; 50(7):697-704. Epub 2011 Jun 11.
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons. [Mol Brain. 2010]
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.
Hu JL, Liu G, Li YC, Gao WJ, Huang YQ. Mol Brain. 2010 Jun 22; 3:20. Epub 2010 Jun 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor inte...
Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
Neuroscientist. 2005 Oct ;11(5):452-70.

PubMed
Hemostatic treatment in the early stage of intracerebral hemorrhage: the recombi...
Hemostatic treatment in the early stage of intracerebral hemorrhage: the recombinant factor VIIa experience.
Stroke. 2005 Oct ;36(10):2321-2. Epub 2005 Sep 8 .

PubMed
Frontal and non-frontal lobe neuropsychological test performance and clinical sy...
Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia.
Psychol Med. 1992 May ;22(2):353-9.

PubMed
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
Science. 2005 Sep 9 ;309(5741):1732-5.

PubMed
Subjective response to neuroleptics and outcome in schizophrenia: a re-examinati...
Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures.
Psychol Med. 1992 May ;22(2):347-52.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: